268 related articles for article (PubMed ID: 23701408)
1. Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition.
Chang JW; Cognetta AB; Niphakis MJ; Cravatt BF
ACS Chem Biol; 2013 Jul; 8(7):1590-9. PubMed ID: 23701408
[TBL] [Abstract][Full Text] [Related]
2. O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.
Niphakis MJ; Johnson DS; Ballard TE; Stiff C; Cravatt BF
ACS Chem Neurosci; 2012 May; 3(5):418-26. PubMed ID: 22860211
[TBL] [Abstract][Full Text] [Related]
3. Selective N-Hydroxyhydantoin Carbamate Inhibitors of Mammalian Serine Hydrolases.
Cognetta AB; Niphakis MJ; Lee HC; Martini ML; Hulce JJ; Cravatt BF
Chem Biol; 2015 Jul; 22(7):928-37. PubMed ID: 26120000
[TBL] [Abstract][Full Text] [Related]
4. Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.
Adibekian A; Martin BR; Wang C; Hsu KL; Bachovchin DA; Niessen S; Hoover H; Cravatt BF
Nat Chem Biol; 2011 May; 7(7):469-78. PubMed ID: 21572424
[TBL] [Abstract][Full Text] [Related]
5. Competitive activity-based protein profiling identifies aza-β-lactams as a versatile chemotype for serine hydrolase inhibition.
Zuhl AM; Mohr JT; Bachovchin DA; Niessen S; Hsu KL; Berlin JM; Dochnahl M; López-Alberca MP; Fu GC; Cravatt BF
J Am Chem Soc; 2012 Mar; 134(11):5068-71. PubMed ID: 22400490
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.
Niphakis MJ; Cognetta AB; Chang JW; Buczynski MW; Parsons LH; Byrne F; Burston JJ; Chapman V; Cravatt BF
ACS Chem Neurosci; 2013 Sep; 4(9):1322-32. PubMed ID: 23731016
[TBL] [Abstract][Full Text] [Related]
7. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates.
Chang JW; Niphakis MJ; Lum KM; Cognetta AB; Wang C; Matthews ML; Niessen S; Buczynski MW; Parsons LH; Cravatt BF
Chem Biol; 2012 May; 19(5):579-88. PubMed ID: 22542104
[TBL] [Abstract][Full Text] [Related]
8. Combining cross-metathesis and activity-based protein profiling: new β-lactone motifs for targeting serine hydrolases.
Camara K; Kamat SS; Lasota CC; Cravatt BF; Howell AR
Bioorg Med Chem Lett; 2015 Jan; 25(2):317-21. PubMed ID: 25541002
[TBL] [Abstract][Full Text] [Related]
9. Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening.
Bachovchin DA; Ji T; Li W; Simon GM; Blankman JL; Adibekian A; Hoover H; Niessen S; Cravatt BF
Proc Natl Acad Sci U S A; 2010 Dec; 107(49):20941-6. PubMed ID: 21084632
[TBL] [Abstract][Full Text] [Related]
10. Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases.
Long JZ; Jin X; Adibekian A; Li W; Cravatt BF
J Med Chem; 2010 Feb; 53(4):1830-42. PubMed ID: 20099888
[TBL] [Abstract][Full Text] [Related]
11. Profiling serine hydrolase activities in complex proteomes.
Kidd D; Liu Y; Cravatt BF
Biochemistry; 2001 Apr; 40(13):4005-15. PubMed ID: 11300781
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes.
Alexander JP; Cravatt BF
Chem Biol; 2005 Nov; 12(11):1179-87. PubMed ID: 16298297
[TBL] [Abstract][Full Text] [Related]
13. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.
Patel JZ; Nevalainen TJ; Savinainen JR; Adams Y; Laitinen T; Runyon RS; Vaara M; Ahenkorah S; Kaczor AA; Navia-Paldanius D; Gynther M; Aaltonen N; Joharapurkar AA; Jain MR; Haka AS; Maxfield FR; Laitinen JT; Parkkari T
ChemMedChem; 2015 Feb; 10(2):253-65. PubMed ID: 25504894
[TBL] [Abstract][Full Text] [Related]
14. Competitive ABPP of Serine Hydrolases: A Case Study on DAGL-Alpha.
Baggelaar MP; Van der Stelt M
Methods Mol Biol; 2017; 1491():161-169. PubMed ID: 27778288
[TBL] [Abstract][Full Text] [Related]
15. Expanding the Toolkit for the Serine Hydrolases.
Ross MK; Wang R
Chem Biol; 2015 Jul; 22(7):808-9. PubMed ID: 26207294
[TBL] [Abstract][Full Text] [Related]
16. Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders.
Deng H; Li W
Acta Pharm Sin B; 2020 Apr; 10(4):582-602. PubMed ID: 32322464
[TBL] [Abstract][Full Text] [Related]
17. Design of Benzoxathiazin-3-one 1,1-Dioxides as a New Class of Irreversible Serine Hydrolase Inhibitors: Discovery of a Uniquely Selective PNPLA4 Inhibitor.
Kornahrens AF; Cognetta AB; Brody DM; Matthews ML; Cravatt BF; Boger DL
J Am Chem Soc; 2017 May; 139(20):7052-7061. PubMed ID: 28498651
[TBL] [Abstract][Full Text] [Related]
18. Organic carbamates in drug design and medicinal chemistry.
Ghosh AK; Brindisi M
J Med Chem; 2015 Apr; 58(7):2895-940. PubMed ID: 25565044
[TBL] [Abstract][Full Text] [Related]
19. Development of a Multiplexed Activity-Based Protein Profiling Assay to Evaluate Activity of Endocannabinoid Hydrolase Inhibitors.
Janssen APA; van der Vliet D; Bakker AT; Jiang M; Grimm SH; Campiani G; Butini S; van der Stelt M
ACS Chem Biol; 2018 Sep; 13(9):2406-2413. PubMed ID: 30199617
[TBL] [Abstract][Full Text] [Related]
20. DIGE-ABPP by click chemistry: pairwise comparison of serine hydrolase activities from the apoplast of infected plants.
Hong TN; van der Hoorn RA
Methods Mol Biol; 2014; 1127():183-94. PubMed ID: 24643562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
